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In a number of ways, I am a personal stakeholder in the 
debate about prenatal testing for Down syndrome. I am a 
woman who has benefited from technologies that have ena-
bled me to control my fertility and make my own repro-
ductive choices. I am the sibling of a much-loved person 
with Down syndrome. It so happens that in addition, I have 
researched and written about the psychosocial and ethical 
aspects of prenatal testing for over 20 years. This quote from 
Barbara Katz Rothman pretty much captures it for me:
“I have never, ever, in my life come across anything 
as complicated as prenatal testing. Morally, psycho-
logically, politically, socially—on every level, I have 
never come up against anything as difficult.” (Rothman 
1997)
To this list of difficulties, I would add ‘personally’. My 
brother, born in the 1970s, changed my life and that of my 
family in so many positive ways despite the negative predic-
tions my parents were subjected to. As a child and teenager, 
I felt that anyone who knew this truth about having a family 
member with Down syndrome would not consider testing 
for or terminating a pregnancy because of the condition. As 
a woman I became more aware of hard-won reproductive 
freedoms and even encountered those who like me had a 
family member with Down syndrome but did not share my 
views or experience. In my first piece of research with sisters 
of a sibling with Down syndrome, positive feelings about 
the sibling were very evident, but one‐third of participants 
viewed the impact on themselves and their family as less 
positive, and this was reflected in them holding favourable 
attitudes towards prenatal testing and termination (Bryant 
et al. 2005).
It can certainly be argued that many things have changed 
for the better since that research was conducted, including 
an increasing awareness that being a parent of a child with 
Down syndrome is something to celebrate not fear. Still, 
people with Down syndrome vary in their abilities and 
physical health, and some have greater educational, sup-
port or healthcare needs than others. The rights and lives 
of people with a learning disability are always precarious; 
something highlighted once again during the Covid-19 
pandemic (Lodge 2020). Many disabled people and their 
families report struggling ‘against the system’ to access the 
education, services and employment opportunities they have 
a right to (Horridge et al. 2019). The public battle for equal-
ity, as well as continued negative, and sometimes openly 
cruel, attitudes towards those with an intellectual disability 
can constrain the choices women feel they have. It is disin-
genuous at the very least to assume individual choices are 
always evidence of autonomy when they may also be evi-
dence of a society’s inability to include and support people 
with intellectual disability. In my work, hearing the personal 
experiences of women who choose to terminate a pregnancy 
for Down syndrome as well as those who choose not to, has 
led me to fully respect the decisions that individual women 
and their partners make. The reality that screening leads to a 
reduction in the population of people with Down syndrome 
is more personally difficult and complicated.
Advocacy groups including ‘Do not Screen Us Out’ in 
the UK argue that government funding of a screening pro-
gramme for Down syndrome is discriminatory, and that a 
diagnosis of the condition is not a valid reason to routinely 
offer termination of pregnancy (Thomas and Rothman 
2016). Heidi Crowter, a self-advocate living with Down 
syndrome, has called for a judicial review to challenge the 
current English law that allows parents to terminate a preg-
nancy for Down syndrome up to full-term (BBC 2020). The 
groups are concerned that the lives of people with Down 
syndrome and their families are inaccurately and negatively 
portrayed by health professionals whose own assumptions 
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and values undermine the ability of women to make a fully 
informed choice (Enoch 2019). They have long raised con-
cerns that the introduction of non-invasive Prenatal Testing 
(NIPT) into the UK’s National Health Service will lead to a 
significant reduction in the population of people with Down 
syndrome.
NIPT, as an earlier and more accurate screening test, is 
in general viewed favourably by pregnant women some of 
whom seek access to it through private services. Not all 
pregnant women choose to screen for Down syndrome (or 
Edwards’ syndrome or Patau’s syndrome now part of the 
combined first trimester screening test). Not all women who 
receive a screen positive result choose diagnostic testing. 
Not all women who receive a diagnosis of Down syndrome 
terminate the pregnancy, but around 90% (in most of the 
UK) do. This proportion has changed remarkably little in 
the time I have been researching in the area (Mansfield 
et al. 1999), despite uptake of prenatal screening over this 
period increasing, and public attitudes towards people with 
Down syndrome becoming more positive (Henderson and 
Redshaw 2017). Knowledge of, and attitudes towards Down 
syndrome, may, however, be less important in a decision to 
choose screening than some other factors such as a desire for 
reassurance about foetal health early in pregnancy (Bryant 
et al. 2010). If the introduction of NIPT into the NHS leads 
to an increased uptake of screening tests across the preg-
nant population, then it is likely the number of terminations 
for Down syndrome will also increase de facto. Early data 
does support this increase in termination numbers (Van den 
Bogaert et al. 2021), although termination rates themselves 
may remain stable (Hill et al. 2017).
Advancing maternal age is associated with an increased 
chance of having a baby with Down syndrome. In the 
absence of screening, the number of live births of babies 
with Down syndrome would almost certainly have grown 
in line with the rise in average maternal age (de Graaf et al. 
2020; Lou et al. 2018); although the knowledge that pre-
natal screening exists may well play a part in the choices 
women make about the timing of their pregnancies. Parents 
have been vocal in demanding support for their children with 
Down syndrome and instrumental in challenging negative 
stereotypes. In an imagined world where no prenatal test-
ing existed, more children with Down syndrome would 
have been born, and many perhaps within families with the 
resources to be agents of positive social change. I sometimes 
wonder what life for my brother would be like if there were 
more, rather than fewer, people with Down syndrome in our 
society. Personal contact with disabled people is associated 
with more positive attitudes towards disability (Keith et al. 
2015), which in turn are associated with less favourable atti-
tudes to termination of an affected pregnancy (Bryant et al. 
2010). Over time, a significant reduction in the number of 
people with Down syndrome would reduce opportunities 
for personal interaction and so potentially further impact on 
personal attitudes. This is not an argument against the rights 
of individual women to screen for, or have a termination of 
pregnancy for Down syndrome, but a personal reflection on 
the complicated nature of prenatal testing as a social as well 
as a medical technology.
A clear understanding of the impact of NIPT on the 
global population of people with Down syndrome will not 
be available for some years and at this point in history, con-
cerns about an imminent ‘world without Down syndrome’ 
can neither be fully supported nor dismissed. In the mean-
time, the quality of the lives of people with Down syndrome 
like my brother, and their family members like me, continue 
to be subject to public scrutiny and debate. Those, including 
myself, who support the right for women to make individual 
prenatal testing and termination decisions must be careful 
not to justify this right at the expense of the humanity and 
value of people with Down syndrome.
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